COMPANY
TECHNOLOGY
TEAM
Board of Directors
Management
Extended Management
Project Management
PARTNERS & ADVISORS
Clinical Advisory Board
Scientific and Drug Development Advisory Board
INVESTORS
NEWS
Company News
Scientific Publications
CONTACT
Company News
Swiss Rockets AG and its subsidiary Torqur AG welcome four key scientific members
20 September 2023
LEARN MORE
Torqur AG's cancer drug candidate bimiralisib with promising new study results
15 May 2023
LEARN MORE
Swiss Rockets AG Welcomes Three New Key Members To The Team
18 April 2023
LEARN MORE
Swiss Rockets further strengthens the development of its phase II cancer drug candidate bimiralisib
23 January 2023
LEARN MORE
Dr. Vladimir Cmiljanovic is a recipient of the 2023 Nikola Tesla Spirit Award
31 January 2023
LEARN MORE